Viewing Study NCT02048358

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:18 AM
Ignite Modification Date: 2026-02-25 @ 11:02 PM
Study NCT ID: NCT02048358
Status: TERMINATED
Last Update Posted: 2015-02-06
First Post: 2014-01-17
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety, Pharmacokinetics and Pharmacodynamics Study With 2B3-201 in Healthy Subjects and Multiple Sclerosis(MS) Patients
Sponsor: BBB-Therapeutics B.V.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy Volunteers View
None Multiple Sclerosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Healthy volunteers View
None first in human View
None 2B3-201 View
None methylprednisolone View
None CNS-targeting View
None liposomal View
None crossover View
None placebo controlled View
None active controlled View
None multiple sclerosis View
None multiple sclerosis relapse View